In last trading session, Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) saw 0.57 million shares changing hands with its beta currently measuring 1.83. Company’s recent per share price level of $0.32 trading at -$0.01 or -4.06% at ring of the bell on the day assigns it a market valuation of $1.61M. That closing price of QNRX’s stock is at a discount of -1831.25% from its 52-week high price of $6.18 and is indicating a premium of 12.5% from its 52-week low price of $0.28.

For Quoin Pharmaceuticals Ltd ADR (QNRX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.43 in the current quarter.

Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) trade information

Upright in the red during last session for losing -4.06%, in the last five days QNRX remained trading in the red while hitting it’s week-highest on Thursday, 02/20/25 when the stock touched $0.32 price level, adding 8.52% to its value on the day. Quoin Pharmaceuticals Ltd ADR’s shares saw a change of -50.93% in year-to-date performance and have moved -3.53% in past 5-day. Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) showed a performance of -45.84% in past 30-days.

Quoin Pharmaceuticals Ltd ADR (QNRX) estimates and forecasts

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -194.79% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 78.42% while estimates for its earnings growth in next 5 years are of 82.69%.